Nicotinamide Mononucleotide

Lawsuit against FDA on NMN ‘certainly being considered’, says NPA CEO

14-Mar-2023 By Stephen Daniells

The Natural Products Association is hoping the US Food & Drug Administration is responsive to its recent Citizen’s Petition on the status of NMN, but if it’s not then other options are being considered, Dr Daniel Fabricant, NPA’s CEO tells NutraIngredients-USA.

‘Here we go again’: NPA and ANH file Citizen’s Petition with FDA for NMN relief

07-Mar-2023 By Stephen Daniells

A new Citizen’s Petition is requesting the FDA reevaluate the status of NMN or exercise Enforcement Discretion on the Drug Exclusion Clause for the ingredient.

Majority of NMN products tested by ChromaDex had virtually none of active ingredient

14-Jan-2022 By Hank Schultz

Supplement manufacturer ChromaDex alleges that testing has revealed that more than half of NMN anti aging supplements being sold on Amazon contained almost none of the bioactive molecule.

Cellular aging category heats up with new NMN product launch

23-Jun-2021 By Stephen Daniells

Developed in collaboration with scientists at the Buck Institute for Research on Aging, the new product called Elevant Prime is formulated with nicotinamide mononucleotide (NMN).